In a new study published in Clinical Gastroenterology and Hepatology, the low FODMAP diet and the antibiotic rifaximin provided similar and significant relief for patients with irritable bowel syndrome with diarrhea (IBS-D).
Gut microbiome characteristics predict treatment response in IBS-D patients
- Post author:admin
- Post published:April 22, 2026
- Post category:uncategorized